# Depression, Anxiety, Stress Symptoms and Health-Related Quality of Life in Hemodialysis Patients: Cross-Sectional Findings from a Romanian Cohort

**Authors:** Adriana-Luciana Luca, Felicia Militaru, Cristina Mariana Văduva, Ilie-Robert Dinu, Daniela Teodora Maria, Mădălina Iuliana Mușat, Virginia Maria Rădulescu, Ion Udriștoiu, Eugen Moța

PMC · DOI: 10.3390/medicina62020242 · 2026-01-23

## TL;DR

This study finds high rates of psychological distress and poor physical quality of life among Romanian hemodialysis patients, suggesting the need for routine mental health screening.

## Contribution

The study provides one of the first detailed characterizations of psychological distress and HRQoL in an Eastern European hemodialysis cohort.

## Key findings

- 48% of patients reported mild depressive symptoms, 34.4% anxiety, and 44% stress symptoms.
- Physical HRQoL was significantly impaired (PCS 36.5 ± 9.6), while mental HRQoL was relatively preserved.
- Stress symptoms were independently associated with lower mental HRQoL, though explained variance was limited.

## Abstract

Background and Objectives: Chronic kidney disease (CKD) and maintenance hemodialysis (HD) are frequently associated with psychological distress and impaired health-related quality of life (HRQoL). However, the relationships between depressive, anxiety, and stress symptoms, clinical factors, and HRQoL remain insufficiently understood in routine care. This study aimed to assess the prevalence of psychological distress and to explore cross-sectional correlates of kidney disease-specific and generic HRQoL in Romanian patients receiving long-term HD, providing one of the first detailed characterizations of these relationships in an Eastern European maintenance HD cohort. Materials and Methods: This single-center cross-sectional study included 125 adult patients undergoing maintenance HD for at least one year. Baseline assessment comprised socioeconomic, demographic and clinical and paraclinical data, including Charlson Comorbidity Index (CCI), dialysis adequacy (spKt/V), cognitive function, psychological distress assessed with the Depression, Anxiety and Stress Scale (DASS-21R), and HRQoL evaluated using the Kidney Disease Quality of Life Short Form (KDQOL-SF™ 1.3). HRQoL domains and physical and mental component summary scores (PCS, MCS) were analyzed using descriptive statistics, correlation analyses, and multivariable linear regression. Follow-up assessments at approximately one year were summarized descriptively. Results: Disease-specific HRQoL revealed marked impairment in perceived disease burden and work status, while physical HRQoL was substantially reduced (PCS 36.5 ± 9.6). Mental HRQoL was relatively preserved (MCS 48.8 ± 8.8). At baseline, 48.0% of patients reported at least mild depressive symptoms, 34.4% anxiety symptoms, and 44.0% stress symptoms. spKt/V showed a modest association with PCS. Psychological distress demonstrated weak associations with HRQoL; stress was independently associated with lower MCS, with limited explained variance (R2 ≤ 0.15). Conclusions: Psychological distress is common among Romanian HD patients and is cross-sectionally associated with markedly impaired physical HRQoL. While the present design does not allow causal inferences, these findings support the implementation of routine psychological screening and the consideration of targeted psychosocial interventions in HD care.

## Linked entities

- **Diseases:** chronic kidney disease (MONDO:0005300)

## Full-text entities

- **Diseases:** hypotension (MESH:D007022), Distress (MESH:D012128), hyperactivity (MESH:D006948), anxiety disorder (MESH:D001008), pruritus (MESH:D011537), frailty (MESH:D000073496), Health-Related Quality (MESH:D000076082), Mood Symptoms (MESH:D019964), fatigue (MESH:D005221), mental disorders (MESH:D001523), congenital deafness (MESH:D003638), congenital or (MESH:D008209), disruption (MESH:D019958), CKD (MESH:D051436), dysphoria (MESH:D019052), Anxiety (MESH:D001007), schizophrenia (MESH:D012559), Comorbidity (MESH:D004194), injury to (MESH:D014947), inflammatory (MESH:D007249), conditions (MESH:D020763), anhedonia (MESH:D059445), pain (MESH:D010146), sleep disorders (MESH:D012893), cognitive impairment (MESH:D003072), disability (MESH:D009069), impaired comprehension or communication (MESH:D003147), musculoskeletal symptoms (MESH:D009140), Kidney Disease (MESH:D007674), depression (MESH:D003866), PCS (OMIM:176430), neurocognitive impairment (MESH:D019965), PD (MESH:D010538), psychological (MESH:D000067073), CCI (MESH:C566784), stress (MESH:D000079225), intellectual disability (MESH:D008607), Life (MESH:D003643)
- **Chemicals:** urea (MESH:D014508)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12942000/full.md

---
Source: https://tomesphere.com/paper/PMC12942000